<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>ntmscope_meta on ntmscope</title>
    <link>http://ntmscope.org/tags/ntmscope_meta/</link>
    <description>Recent content in ntmscope_meta on ntmscope</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year}</copyright>
    <lastBuildDate>Thu, 27 Jun 2024 00:00:00 +0000</lastBuildDate>
    
	    <atom:link href="http://ntmscope.org/tags/ntmscope_meta/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>New publication in the Journal of Infection</title>
      <link>http://ntmscope.org/news/post18/</link>
      <pubDate>Thu, 27 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>http://ntmscope.org/news/post18/</guid>
      <description>&lt;img src=&#34;gr1.jpg&#34;&gt;
&lt;br&gt;
&lt;i&gt;Mycobacterium malmoense&lt;/i&gt; is a rare cause of NTM pulmonary disease. In this systemativ review and meta-analysis, we summarize the available clinical data of &lt;i&gt;M. malmoense&lt;/i&gt; infection from more than 800 patients. The pathogen is shown to be of high clinical relevance and macrolide or rifamycin containing regimens might imrpove survival in affected patients.  
&lt;br&gt;&lt;br&gt;
We are very happy to see the result of this Danish-German collaboration finally published in the Journal of Infection.
&lt;br&gt;&lt;br&gt;
You can find the paper here, at 
&lt;a href=&#34;http://ntmscope.org/publication/yjinf_2024&#34;&gt;ntmscope.org&lt;/a&gt;, &lt;a href=&#34;https://www.journalofinfection.com/article/S0163-4453(24)00137-3/fulltext&#34;&gt; the journal&#39;s homepage&lt;/a&gt;, or at &lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38906266/&#34;&gt;PubMed&lt;/a&gt;.
</description>
    </item>
    
    <item>
      <title>Clinical spectrum and relevance of Mycobacterium malmoense: Systematic review and meta-analysis of 859 patients</title>
      <link>http://ntmscope.org/publication/yjinf_2024/</link>
      <pubDate>Wed, 19 Jun 2024 00:00:00 +0000</pubDate>
      
      <guid>http://ntmscope.org/publication/yjinf_2024/</guid>
      <description>&lt;p&gt;&lt;a href=&#34;https://www.journalofinfection.com/article/S0163-4453(24)00137-3/fulltext&#34;&gt;At Journal Homepage&lt;/a&gt;
&lt;br&gt;
&lt;br&gt;
&lt;a href=&#34;https://pubmed.ncbi.nlm.nih.gov/38906266/&#34;&gt;At PubMed&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>ESM Paper of the Quarter award</title>
      <link>http://ntmscope.org/news/post04/</link>
      <pubDate>Mon, 04 Jul 2022 00:00:00 +0000</pubDate>
      
      <guid>http://ntmscope.org/news/post04/</guid>
      <description>&lt;img src=&#34;featured.png&#34;&gt;
&lt;br&gt;
The ntmscope-publication &#34;High overall mortality of &lt;i&gt;Mycobacterium genavense&lt;/i&gt; infections and impact of antimycobacterial therapy: Systematic review and individual patient data meta-analysis&#34; has been awarded ESM&#39;s &#34;Paper of the Qarter Award&#34; for Q4 2021.
&lt;br&gt;
&lt;br&gt;
We are very thankful for the positive feedback. The prize money will be invested in future and ongoing ntmscope-projects.
&lt;br&gt;
&lt;br&gt;
See the news at the European Society of Mycobacteriology&#39;s &lt;a href=&#34;https://www.esmycobacteriology.eu/paper-of-the-quarter&#34;&gt;homepage&lt;/a&gt;
&lt;br&gt;
&lt;br&gt;
See the publication at &lt;a href=&#34;http://ntmscope.org/publication/yjinf_2021&#34;&gt;ntmcope.org&lt;/a&gt;</description>
    </item>
    
  </channel>
</rss>
